VEGFA and peripheral arterial disease: For example, a randomised controlled trial (RCT) has not shown a constant efficiency of the neovasculature in PAD patients, while it has indicated vascular growth effects of Ad-mediated VEGF-A and plasmid gene therapy [168,169,170].